1
2
3
4
5
6
7
8
9
10
11
12
13 | On 05/08/2026, Licensing Program Analyst (LPA) Socorro Leandro conducted an unannounced continuation complaint investigation visit regarding the allegations listed above. LPA met with the Executive Director, Suzette Johnson, and the purpose of the visit was explained. LPA was granted entry to the facility.
Investigation consisted of the following:
On 1/29/2026, a facility tour was conducted and Resident 1 (R1) to Resident 10 (R10) and Witness 1 (W1) to Witness 2 (W2) were interviewed. On 04/09/2026, a facility tour was conducted and Staff 1 (S1) to Staff 13 (S13) and Resident 11 (R11) to Resident 14 (R14) were interviewed. On 4/10/2026, nine resident Medication Administration Records (MARs) were reviewed along with their medications. On 05/05/2026, Witness 1 (W1) to Witness 9 (W9) were interviewed. On 05/06/2026, Witness 10 (W10) was interviewed. On 05/08/2026, Witness 11 (W11) to Witness 13 (W13) were interviewed. Records were gathered and reviewed. |